Contact
Kirkham Young Ltd.
7 Watch Oak Business Centre, Chain Lane, Battle, East Sussex
TN33 0GB
- T
- +44 (0)1424 777745
- F
- +44 (0)1424 777746
- E
- info@kirkhamyoung.co.uk
Trial success bodes well for ‘pharmacy-on-a-chip’
17/02/2012
Medical technology developers in the USA and Denmark have made a huge breakthrough in the development of microchip implants that release medicine straight into patients’ bodies.
A recent clinical trial of the scientific devices has been hailed a huge success for the implantable ‘pharmacy-on-a-chip’. The trial saw seven women with osteoporosis have the devices implanted under their skin for 20 days in a test that was aimed at assessing the safety of the technology.
The chips replaced the daily hormone injections that the women have to endure to manage the bone disease, and released a dose of their drugs at specific times during the day.
Robert Farra, the president of the Massachusetts-based company behind the technology, MicroCHIPS, said that they were extremely pleased about the potential of the devices.
“Once the patient has had the chip implanted, there’s nothing else they need to do,” he said. “They no longer have to worry about taking their medication or the pain of daily injections.”
The chips, which are around the size of a domino, where inserted into the women just below their waistlines, in procedures that required nothing more than local anaesthetic.
The success of the trial could open up a wide range of avenues for the development of the chips, for use with many diseases that require very specific doses of medicine at precisely timed intervals throughout the day.
A recent clinical trial of the scientific devices has been hailed a huge success for the implantable ‘pharmacy-on-a-chip’. The trial saw seven women with osteoporosis have the devices implanted under their skin for 20 days in a test that was aimed at assessing the safety of the technology.
The chips replaced the daily hormone injections that the women have to endure to manage the bone disease, and released a dose of their drugs at specific times during the day.
Robert Farra, the president of the Massachusetts-based company behind the technology, MicroCHIPS, said that they were extremely pleased about the potential of the devices.
“Once the patient has had the chip implanted, there’s nothing else they need to do,” he said. “They no longer have to worry about taking their medication or the pain of daily injections.”
The chips, which are around the size of a domino, where inserted into the women just below their waistlines, in procedures that required nothing more than local anaesthetic.
The success of the trial could open up a wide range of avenues for the development of the chips, for use with many diseases that require very specific doses of medicine at precisely timed intervals throughout the day.
RSS
